A, M., G, B., B, F., C, I., F, M., A, M., . . . L, M. (2022). Autologous haematopoietic stem cell transplantation versus low-dose immunosuppression in secondary-progressive multiple sclerosis. European journal of neurology, 29(6), 1708. https://doi.org/10.1111/ene.15280
Chicago Style (17th ed.) CitationA, Mariottini, et al. "Autologous Haematopoietic Stem Cell Transplantation Versus Low-dose Immunosuppression in Secondary-progressive Multiple Sclerosis." European Journal of Neurology 29, no. 6 (2022): 1708. https://doi.org/10.1111/ene.15280.
MLA (9th ed.) CitationA, Mariottini, et al. "Autologous Haematopoietic Stem Cell Transplantation Versus Low-dose Immunosuppression in Secondary-progressive Multiple Sclerosis." European Journal of Neurology, vol. 29, no. 6, 2022, p. 1708, https://doi.org/10.1111/ene.15280.